Prognostic value of pretreatment cardiovascular biomarkers in head and neck squamous cell carcinoma.
Karine Gadioli de OliveiraMarcela Marçal ThebitTadeu Uggere de AndradeFabiana Vasconcelos CamposJose Roberto Vasconcelos PodestáSandra Lucia Ventorin Von ZeidlerNazaré Souza BissoliSonia Alves GouveaPublished in: Oral diseases (2020)
Pretreatment CRP and NT-proBNP levels were identified as independent prognostic markers for poor clinical outcome 3 years after HNSCC diagnosis.
Keyphrases